APA (7th ed.) Citation

Cortes-Selva, D., Perova, T., Skerget, S., Vishwamitra, D., Stein, S., Boominathan, R., . . . Verona, R. I. (2024). Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study. Blood, 144(6), 615. https://doi.org/10.1182/blood.2023022823

Chicago Style (17th ed.) Citation

Cortes-Selva, Diana, et al. "Correlation of Immune Fitness with Response to Teclistamab in Relapsed/refractory Multiple Myeloma in the MajesTEC-1 Study." Blood 144, no. 6 (2024): 615. https://doi.org/10.1182/blood.2023022823.

MLA (9th ed.) Citation

Cortes-Selva, Diana, et al. "Correlation of Immune Fitness with Response to Teclistamab in Relapsed/refractory Multiple Myeloma in the MajesTEC-1 Study." Blood, vol. 144, no. 6, 2024, p. 615, https://doi.org/10.1182/blood.2023022823.